Can Chinese Companies Still Invest in the United States? The Impact of FIRRMA  

作　　者：Paul B. Edelberg 

机构地区：[1]Fox Rothschild LLP, New York, USA

出　　处：《US-China Law Review》2019年第1期12-20,共9页美中法律评论（英文版）

摘　　要：The Foreign Investment Risk Review Act,or FIRRMA,signed by President Trump on August 13,2018,significantly expanded the scope of transactions involving foreign investment in U.S.companies that are covered by the national security laws of the U.S.,commonly known as the CFIUS regime.Certain minority investments and certain technology-related investments may now need to be submitted to the Committee on Foreign Investment in the U.S.(CFIUS)for clearance.FIRRMA also implements an expedited filing process,which in some cases is mandatory,and expands the authority and enforcement tools of CFIUS.This new law in part targets China’s investments in the U.S.and its attempts to procure U.S.-based technology.This article discusses the new law and analyzes the implications of the law on Chinese investment in the U.S.

关 键 词：CFIUS FIRRMA critical TECHNOLOGIES emerging and foundational TECHNOLOGIES MINORITY INVESTMENTS foreign ACQUISITIONS declarations national security 

分 类 号：D[政治法律]